Answers are grounded in this paper and cite their sources.
Case report shows ta-nVNS reduces migraine frequency in elderly individuals, suggesting a potential treatment option.
Migraine is a disabling neurological disorder that may progress to chronic or resistant forms, which are especially challenging to manage in elderly patients. Transauricular non-invasive vagus nerve stimulation (ta-nVNS) has recently gained recognition as a safe supplementary treatment for migraines in adults; however, there is limited data available for individuals over the age of 65. We report the case of a 67-year-old male with chronic resistant migraine refractory to three pharmacological prophylactic classes. The patient participated in biweekly ta-nVNS sessions for a period of 6 weeks, which led to a marked decrease in both the frequency and intensity of headaches, alongside improvements in headache impact test scores and heart rate variability indices. When symptoms reappeared after several weeks, they were effectively managed with a second course of ta-nVNS, administered once a week. ta-nVNS appears to be an effective, non-invasive adjunct therapy for chronic resistant migraine in elderly individuals, showing beneficial modulation of autonomic function and migraine burden.
No takes yet. Share an insight, caveat, or question.
Rana et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: